DE602007013405D1 - Verfahren zur bestimmung der prognose eines adenokarzinoms - Google Patents

Verfahren zur bestimmung der prognose eines adenokarzinoms

Info

Publication number
DE602007013405D1
DE602007013405D1 DE602007013405T DE602007013405T DE602007013405D1 DE 602007013405 D1 DE602007013405 D1 DE 602007013405D1 DE 602007013405 T DE602007013405 T DE 602007013405T DE 602007013405 T DE602007013405 T DE 602007013405T DE 602007013405 D1 DE602007013405 D1 DE 602007013405D1
Authority
DE
Germany
Prior art keywords
adenocarcinoma
prognosis
determining
organ
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007013405T
Other languages
English (en)
Inventor
Curtis C Harris
Masahiro Seike
Xin Wei Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Government
Original Assignee
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Government filed Critical US Government
Publication of DE602007013405D1 publication Critical patent/DE602007013405D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
DE602007013405T 2006-07-14 2007-07-16 Verfahren zur bestimmung der prognose eines adenokarzinoms Active DE602007013405D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83093606P 2006-07-14 2006-07-14
US88510107P 2007-01-16 2007-01-16
PCT/US2007/073637 WO2008009028A2 (en) 2006-07-14 2007-07-16 Methods of determining the prognosis of an adenocarcinoma

Publications (1)

Publication Number Publication Date
DE602007013405D1 true DE602007013405D1 (de) 2011-05-05

Family

ID=38670673

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007013405T Active DE602007013405D1 (de) 2006-07-14 2007-07-16 Verfahren zur bestimmung der prognose eines adenokarzinoms

Country Status (5)

Country Link
US (1) US9464324B2 (de)
EP (1) EP2041313B1 (de)
AT (1) ATE503025T1 (de)
DE (1) DE602007013405D1 (de)
WO (1) WO2008009028A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110183859A1 (en) * 2008-09-25 2011-07-28 The United States Of America, As Represented By The Secretary, Inflammatory genes and microrna-21 as biomarkers for colon cancer prognosis
RU2455924C1 (ru) * 2011-03-30 2012-07-20 Учреждение Российской академии наук Институт физиологии природных адаптаций Уральского отделения Российской академии наук Способ прогнозирования метастазирования опухолевого процесса у больных раком желудка
WO2015125098A2 (en) 2014-02-24 2015-08-27 Immunepharma S.R.L. Lung cancer's biomarkers and their methods and diagnostic kit

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985829A (en) 1994-12-19 1999-11-16 The United States Of America As Represented By The Department Of Health And Human Services Screening assays for compounds that cause apoptosis and related compounds
US6368598B1 (en) 1996-09-16 2002-04-09 Jcrt Radiation Oncology Support Services, Inc. Drug complex for treatment of metastatic prostate cancer
US6960570B2 (en) 1998-03-18 2005-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7049063B2 (en) 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
CA2398107C (en) 2000-01-28 2013-11-19 Althea Technologies, Inc. Methods for analysis of gene expression
US7171311B2 (en) 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
EP1410011B1 (de) 2001-06-18 2011-03-23 Rosetta Inpharmatics LLC Diagnose und prognose von brustkrebspatientinnen
AU2002343443A1 (en) * 2001-09-28 2003-04-14 Whitehead Institute For Biomedical Research Classification of lung carcinomas using gene expression analysis
AU2003230838A1 (en) 2002-04-05 2003-10-27 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Methods of diagnosing potential for metastasis or developing hepatocellular carcinoma and of identifying therapeutic targets
WO2004005891A2 (en) * 2002-07-10 2004-01-15 The Regents Of The University Of Michigan Expression profile of lung cancer
AU2003286840A1 (en) 2002-11-04 2004-06-07 The United States Of America, As Represented By The Secretary Of Defense Methods and compositions for the diagnosis of neuroendocrine lung cancer
US20030153013A1 (en) * 2002-11-07 2003-08-14 Ruo-Pan Huang Antibody-based protein array system
EP1578940A4 (de) * 2002-11-13 2007-12-12 Genentech Inc Verfahren und zusammensetzungen zur dysplasiediagnose
AU2003900747A0 (en) * 2003-02-18 2003-03-06 Garvan Institute Of Medical Research Diagnosis and treatment of pancreatic cancer
US20040229225A1 (en) * 2003-05-16 2004-11-18 Jose Remacle Determination of a general three-dimensional status of a cell by multiple gene expression analysis on micro-arrays
WO2005015236A2 (en) 2003-07-18 2005-02-17 Roche Diagnostics Gmbh A method for predicting the progression of adenocarcinoma
WO2006060653A2 (en) 2004-11-30 2006-06-08 Veridex Llc Lung cancer prognostics
EP1777523A1 (de) * 2005-10-19 2007-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) In-vitro-Verfahren zur Prognose einer Tumorprogression und des Ergebnisses bei einem Patienten sowie Mittel zur Durchführung dieses Verfahrens
WO2007140352A2 (en) * 2006-05-26 2007-12-06 Invitrogen Corporation Plasma membrane and secreted cancer biomarkers

Also Published As

Publication number Publication date
ATE503025T1 (de) 2011-04-15
EP2041313A2 (de) 2009-04-01
US9464324B2 (en) 2016-10-11
WO2008009028A2 (en) 2008-01-17
US20090258789A1 (en) 2009-10-15
WO2008009028A3 (en) 2008-04-10
EP2041313B1 (de) 2011-03-23

Similar Documents

Publication Publication Date Title
ATE446790T1 (de) Verfahren zur bestimmung der reichweite von strahlung
WO2006113747A3 (en) Diagnostic markers of breast cancer treatment and progression and methods of use thereof
DE60329377D1 (de) Methode zur vorhersage der sepsis in einem patienten mit systemischem inflammatorischem response-syndrom (sirs)
NZ590385A (en) Signatures and determinants associated with metastasis and methods of use thereof
DE602004032375D1 (de) Verfahren zur l-aminosäureherstellung mittels fermentation
AR053272A1 (es) Determinacion de responsivos a la quimioterapia
TW200745556A (en) Biomarkers for liver fibrotic injury
EP1860553A3 (de) Verfahren und Vorrichtung zur Virtualisierung von Fensterinformationen
ATE469917T2 (de) Verfahren zur gewinnung von antikörpern
WO2009019370A3 (fr) Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal
ATE503025T1 (de) Verfahren zur bestimmung der prognose eines adenokarzinoms
NZ551782A (en) Agents and methods for diagnosing stress
NZ609938A (en) Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
WO2009019367A3 (fr) Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
ATE446384T1 (de) Verfahren zur amplifikation von nukleinsäuren mittels promotor-templates
WO2009003706A3 (en) Methods, kits, and compounds for determining responsiveness to treatment of a pathological disorder by epothilones
WO2007023191A3 (de) Polypeptidmarker zur diagnose von blasenkrebs
ATE157402T1 (de) Verfahren zur bestimmung von salmonella
DE50313671D1 (de) Verfahren zur generierung eines gentechnisch veränderten organismus für das wirksubstanzscreening
MXPA03002863A (es) Valoracion de cancer colorrectal.
DE602004011228D1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
ATE486964T1 (de) Molekulares verfahren zur diagnose von prostatakrebs
RU2011142986A (ru) Способы лечения и диагностики рака
WO2005096693A3 (fr) Procede pour le pronostic et/ou le diagnostic d'un cancer
Guangli et al. Expression of vascular endothelial growth factor and cyclooxygenase-2 in laryngeal squamous cell carcinoma and its significance